Second Shot In Clinical Trial Of Novavax COVID Vaccine Comes With A Dose Of Confidence
Data from studies done in the United Kingdom show the COVID-19 vaccine made by Novavax is roughly 90% effective. CBS4 Health Specialist Kathy Wash is a volunteer in the Phase 3 clinical trial in the U.S.